program
Navigation Links
program at medicine technology
Monitoring Patient Glucose Levels: New Advances in software make it easier
...aching tool. Nearly half of all who download this program are diabetic patients or family members, but it is... first. TheraSenses Freestyle Co-Pilot is another program that allows patients with Internet Explorer web browsers to upload their glucose monitor readings an...When Volume Matters, Immunoassay Systems Deliver
...stem runs from an external PC with a Windows-based program and mouse control. MultiCalc software allows direct linkages to a mainframe or LAN. Bayer HealthCare Diagnostic Division, Tarrytown, N.Y., a unit of the German firm Bayer AG, produces the ADVIA Centaur system, designed for flexible operation and inte...New Quality Control Systems for Every Laboratory Application
...lytical performance. For example, Bio-Rad offers a program whereby customer's daily QC results can be transmi...They will work with labs to design a customized QC program to verify the accuracy and precision of analytical methods. Betsy Donnelly has 30 years of experien...Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
...a testing on one platform, offering 3-minute HbA1c program or 6.5-minute HbA2/F/A1c dual program options. The G7 manufactured by Tosoh Bioscience, Inc., San Francisco, CA, is a fully automated gly...Choosing Lab Quality Management Software
...get budget approval for the purchase of a software program which would automate the more time-consuming aspects of quality management and accreditation management. Nowadays, its not necessarily about cost savings, says Thurber, its more about time savings: because of staffing pressures, labs need to make bet......is of Data from ADVATE(R) Prospective Trials)study program database showing a statistically significantrelati...is of Data from ADVATE Prospective Trials)research program was initiated to further investigate and explorethe expanding ADVATE clinical study program database...New Information on the Potential of Plasmin Shared at ISTH Congress
...epresenting the continuing research anddevelopment program for Plasmin (Human), TAL-05-00018, waspresented by Talecris Biotherapeutics, Inc.(http://www.talecris.com) this week at the XXIst InternationalSociety for Thrombosis and Haemostasis (ISTH) Congress in Geneva,Switzerland. The information included new ......ve initiated the collaborative clinicaldevelopment program that has enrolled a total of more than 4,000patien.... Theglobal ACTEMRA Phase III clinical development program is designedto evaluate this clinical finding. The compound is not currentlyapproved in the United St......geting specific genes in the body, AVI's antiviral program usesNEUGENE antisense compounds to combat disease by targetingsingle-stranded RNA viruses, including West Nile virus, hepatitis Cvirus, dengue virus, Ebola virus and influenza A virus. AVI'sNEUGENE-based ESPRIT technology will initially be applied to...Protox Announces Positive Clinical Data from Prostate Cancer Study
... results at this stage of theclinical development program in a patient population whichhas limited therapeutic options," said Dr. Fahar Merchant,President and Chief Executive Officer of Protox. "These datasupport our heightened confidence regarding the potential ofPRX302 for the treatment of not only pro......lasmaproteins and monoclonal antibodies. The first program of thecollaboration will be to develop recombinant human factor VIIa as apotential treatment for hemophilia in patients with antibodies toother coagulation factors. In 2006, GTC was granted a patent in the United States through2021 for the productio......Additional Phase III results of the ongoing RECORD program areexpected to be available during H2 2007. Unmet Needs in Venous Thromboembolism (VTE) VTE is a type ofthromboembolic disease that affects approximately 6.5 millionpeople worldwide annually. Thromboembolic disease, which is causedby the obstruction......tion continuestoday with a substantial development program focused on thesefields, as well as immune disease, infectious disease, and otherareas of unmet medical need. This press release contains forward-looking statements,including statements regarding the potential for commercializingtolevamer in the futu......MC125 Expanded Access Program The expanded access program (EAP) for TMC125 is now open in anumber of European countries, Canada and the United States. TMC125is available to HIV-1 infected adults, at least 18 years old, whohave limited treatment options either due to virological failure orintolerance to mult...... has also recentlyinitiated a clinical development program with its Lipid PolymerMicelle ("LPMTM") oral drug delivery technology for the oraldelivery of leuprolide for the treatment of prostate cancer andendometriosis. Through its Biodefense Division, DOR is developing biomedicalcountermeasures pursuant to ......tates and Canada. Androxal(TM), the Company'sother program in late clinical development, is designed to resto...llthree programs to lay out the remaining clinical program pathwayrequired before a New Drug Application may be submitted for eachproduct candidate. For more ...Avexa's Apricitabine Clinical Trial Update
...-resistant bacterialinfections. The Company's lead program is apricitabine (ATC) whichhas recently successfully completed the 21 day dosing of its PhaseIIb trial. The Company continues to progress ATC towards Phase IIItrials. Avexa has entered into a collaboration with TargetDrug inChina to identify new CCR5...Genzyme Announces Results of Clinical Trial of Hylastan
... knee. Hylastan is beingdeveloped within Genzyme's program to introduce aviscosupplementation product that ca...broader number of patients. Genzyme's development program also includes Synvisc-One(TM), aninvestigational combined-dose regimen of Synvisc(R) (hylan G-F 20)p...Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
... providing guidance on malariatechnical issues and program interventions; assisting in countryprograms, program facilitation, policy coordination, coherence andimplementation among all U.S. Government (USG) agenc......estudies, Portola intends to initiate its Phase II program in thesecond half of 2007. About Portola Pharmaceuticals, Inc. Portola Pharmaceuticals, Inc. is a privately-heldbiopharmaceutical company dedicated to the discovery, developmentand commercialization of novel therapeutics for acute and chroniccardio...... has also recentlyinitiated a clinical development program with its Lipid PolymerMicelle ("LPMTM") oral drug delivery technology for the oraldelivery of leuprolide for the treatment of prostate cancer andendometriosis. Through its Biodefense Division, DOR is developing biomedicalcountermeasures pursuant to ...Alkermes Announces Positive Results from Phase 1/2 Clinical Study of ALKS 29
... company plans to move forward with itsdevelopment program for oral product candidates to treat alcoholdependence. ALKS 29 is a combination of two agents with distinctpharmacologic properties designed to provide advantages overcurrent oral medications for the treatment of alcohol dependence.In the study, ALK...Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
...ponsored by NCI arecomponents of a clinical trials program designed to identifysignals of clinical activity o...een the subject of a broad Phase II clinicaltrials program under the sponsorship of GlaxoSmithKline (GSK) andis also being developed in collaboration with the ....... Dr. Andrzej Jakubowiak, Director of the myeloma program at theUniversity of Michigan Cancer Center, presen...nex is in apivotal Phase III and Phase IV clinical program under a SpecialProtocol Assessment with the Food & Drug Administration.Additionally, Keryx is de...... injuries," saidGeffner, director of the stem cell program at the Junta deBeneficencia de Guayaquil. He emphasized that this work was donewith the help and support of the Junta de Beneficencia, BenemeritaSociedad de Lucha Contra el Cancer (SOLCA), and with the researchsupport and pre-clinical studies perform...Opexa Advances Monocyte Derived Islet Technology to Proof of Principle in stz-induced NOD/SCID Mice
...nt research from Opexa'sinnovative adult stem cell program regarding the development ofadult monocyte-derived...ignificantadvancement of our stem cell development program and serve asproof-of-principle for our adult diabetes mellitus beta-cellreplacement therapy developm......ceed at establishing a successfulcommercialization program for any of our potential products.Readers are cautioned that the plans, intentions or expectationsdisclosed in any forward-looking statements and underlyingassumptions may not be achieved and that they should not placeundue reliance on any forward-lo...Two Phase III clinical trials on corifollitropin alfa (Org 36286) reach randomization target
...rgets.” A third Phase III trial in the LIFE program (the TRUST trial)focuses on safety of repeated tre...injection of corifollitropin alfa. • The LIFE program is Organon’s clinical developmentprogram for corifollitropin alfa for the therapeutic indicati.......com/">http://www.avigen.com . As part of its program investigating glial attenuation as anovel approach to the treatment of neuropathic pain, Avigendiscovered that AV411 was efficacious in standard animal models ofthis condition. While ibudilast was initially developed as anon-selective phosphodiestera......0 percent ofcases. Expanding clinical development program for sitagliptinfamily Merck's clinical development program for sitagliptin is robustand continues to expand with 47 studies completed or under way, andnine mor...SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
...tes progress and upcomingmilestones on its insulin program - CALGARY, June 26, 2007 /PRNewswire-FirstCall/ - SemBioSysGenetics Inc. , a biotechnology company developing a portfolio oftherapeutic proteins for metabolic and cardiovascular disease,today announced positive preclinical data supporting thedevelopm......sk areas for MRSA within thehospital; surveillance program to outline activities and proceduresto identify MRSA cases; adherence to CDC hand hygiene guidelines;use of contact precautions (e.g., gloves, gowns and separating MRSApatients from other patients); environmental and equipment cleaningand decontamina......Lipitor is supported by an extensiveclinical trial program involving more than 400 ongoing andcompleted trials with more than 80,000 patients. Important Safety Information Lipitor is a prescription medication. It is used in patientswith multiple risk factors for heart disease such as familyhistory, high bl......ernative Investment Market(PSG). An ADR -- Level 1 program has been established in the USwith the Bank of New York (PPGNY) for US investors to trade inPhosphagenics' stock on the "over-the-counter" market. For more information, please visit Phosphagenics' web site at<a target="_blank" href="http://www.p......Phase 1 clinical data from its ZFP Therapeutic(TM) program at the67th Scientific Sessions of the American Dia.... The most advanced ZFP Therapeutic(TM)development program is currently in Phase 2 clinical trials forevaluation of safety and clinical effect in patients with......0 percent ofcases. Expanding clinical development program for sitagliptinfamily Merck's clinical development program for sitagliptin is robustand continues to expand with 47 studies completed or under way, andnine mor......nedione (TZD) and insulin. In the Galvus clinical program no evidence has been seen ofoverall weight gain[7] or hypoglycemia (dangerously low blood sugarlevels)[8], side effects commonly associated with some type 2diabetes medications. The overall incidence of side effects,including edema (fluid retention),......ra is committed to directing resources to its core program andthe aggressive clinical development of its key assets to buildstockholder value. <a target="_blank" href="http://www.genaera.com/">http://www.genaera.com . This announcement contains forward-looking statements within themeaning of the Pri......protection on allaspects of the ghrelin antagonist program including composition ofmatter protection covering five novel compound classes and theirtherapeutic uses. About Elixir Pharmaceuticals Elixir is a Cambridge, MA-based biopharmaceutical companyfocused on developing and commercializing drugs to treat...Malvern initiates European user group meetings for chemical imaging
...ined Malvern's technical and scientificteams for a program that included oral and poster presentations onthe application of NIR-CI, and the opportunity to exchangeexperiences and ideas. During the first sessions, presentations from users included:'Chemical imaging and quality by design'; 'Moving NIR chemica...AMIA Announces 2008 Summit on Translational Bioinformatics
...Francisco, California. A call for participationand program will be announced in the near future. For moreinformation about AMIA's translational bioinformatics activities,visit the AMIA web site at: <a target="_blank" href="http://www.amia.org/">http://www.amia.org . Contact: Tia Abner ...PromegaExpress Expands Easy Access to Products with New Cabinet
... 21, 2007 - ThePromegaExpress(TM) on-site stocking program just added a newlysized ambient cabinet to its line of on-site appliances. Thislatest addition serves as great option to meet individual labinventory requirements for smaller areas when space is at a premiumbut immediate access to life science tools ...GenoLogics Announces Bioinformatics Partnership with Illumina
...ipant in IlluminaConnect, abioinformatics software program established by Illumina to advancedata integration and analysis among the life science community. GenoLogics will build integrations into Geneus that supportIllumina?s BeadArray technology platforms and software for bothgene expression and genotypin......nex is in a pivotal Phase III and PhaseIV clinical program under a Special Protocol Assessment, or SPA,with t...nex is in apivotal Phase III and Phase IV clinical program under a SpecialProtocol Assessment with the Food & Drug Administration.Additionally, Keryx is de...... Budesonide (UDB) pediatric asthma therapyclinical program at the World Asthma Meeting at the Lutfi KirdarConvention and Exhibition Center in Istanbul, Turkey. The oral and poster presentation entitled, "Efficacy and safetyof a novel submicron particle formulation of budesonide fornebulized delivery in a 6 ...Pharmexa A/S (DK) - Pharmexa presents data from influenza program
... presented selected data fromits influenza vaccine program today at the Influenza Conferenceentitled, "Options for the Control of Influenza VI," held inToronto, Ontario, Canada. The company's "universal" vaccinestrategy combines the use of multiple technologies developed overthe past decade. Specifically, th...Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
...m. Program Design The Phase 3 CAP clinical trial program is comprised of tworandomized, well controlled, double-blind, multi-center,multi-national, comparator trials designed to assess the safety andeffectiveness of cethromycin in CAP patients compared to Biaxin(R).Trial CL-06 enrolled patients from clinic...Amylin Pharmaceuticals to Present New Data from Broad Diabetes and Obesity Programs at ADA 2007
...erapeutic potential to patients. Ourbroad clinical program is designed to continue transforming thecare of diabetes and obesity." KEY AMYLIN ABSTRACTS BEING PRESENTED AT ADA: 1. Oral: "Less Hypoglycemia with Exenatide Versus Insulin Glargine, Despite Similar HbA1c Improvement in Patients with T...First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
...del and we aredelighted to be part of this dynamic program to discover a newfrontier in medicine. We are actively seeking pharmaceuticalpartnerships to help us accelerate the development and validationprocess of these new and exciting compounds." Allergy is the fifth leading chronic disease in the UnitedS...New Flu Vaccine from PepTcell Could Provide Immunity Against All Strains of Influenza Virus
...iling and theinitiation of a worldwide vaccination program ahead of anoutbreak." PepTcell is in the process of finalising all the manufacturingprocesses for its vaccines, and expects FLU-v to enter Phase Iclinical trials during 2008. -ENDS- NOTES FOR EDITORS About the European Journal of Immunology Greg...BioCryst Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference
...ant component of the company'sclinical development program for peramivir, a neuraminidaseinhibitor being developed for the treatment of seasonal andpotentially life-threatening influenza. Top-line data aresummarized as follows: -- A total of 51 healthy adult volunteers received either one of three ...Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
... have made todate in our multi-faceted development program for Renvela,including filing an NDA for patients o...tion continuestoday with a substantial development program focused on thesefields, as well as immune disease, infectious disease, and otherareas of unmet medic......mated atapproximately USD 6 billion. The clinical program for the 57-57 project with the mainindication SLE is proceeding according to plan. This studycomprises patients with SLE or rheumatoid arthritis (RA). This is amulti-center study and is being conducted at three hospitals inSweden - the Karolinska Uni...Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
...have made to date inour multi- faceted development program for Renvela, includingfiling an NDA for patients o...tion continuestoday with a substantial development program focused on thesefields, as well as immune disease, infectious disease, and otherareas of unmet medic...New Flu Vaccine From PepTcell Could Provide Immunity Against All Strains of Influenza Virus
...iling and theinitiation of a worldwide vaccination program ahead of anoutbreak." PepTcell is in the process of finalising all the manufacturingprocesses for its vaccines, and expects FLU-v to enter Phase Iclinical trials during 2008. Notes for Editors About the European Journal of Immunology Gregory A St......ment team in San Diego is pursuing a drugdiscovery program focused on novel approaches to apoptosis. Forward-Looking Statements This news release and any oral statements made with respect tothe information contained in this news release, containsforward-looking statements within the meaning of the PrivateS......ated a collaborative Phase IIIclinical development program in RA that is underway outside Japanwith more than 4,000 patients have been recruited in 41 countriesincluding several European countries and the USA. The compound isnot currently approved in the United States. The most common adverse events reporte......ed with therapid progress in the CF502 development program and with thein-vitro and in vivo trial results showing impressiveanti-inflammatory activity for this drug. Elucidation of CF502mechanism of action and the ability to examine this activity inhuman cells improve the chances that this drug can offer eff......ess, timing and results of ourclinical development program for PRX-00023 and other drugcandidates. These statements are neither promises nor guarantees,but are subject to a variety of risks and uncertainties, many ofwhich are beyond our control, and which could cause actual resultsto differ materially from t...Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial
...odulators of survivin function and adrug discovery program targeting the MYC oncoprotein, one of themost important and previously intractable cancer targets. Thecompany has value generating partnerships with Merck, MedImmune,Medarex, and Novartis. Avalon Pharmaceuticals was established in1999 and is headquar...Other ContentsretinoblastomaretinoblastomaretinoblastomaejaculationejaculationretrograderetrograderetrograderheumaticrheumaticrheumaticrhabdomyosarcomarheumatismOther TagsMexMexOTSOTSOTSOTSApplierAspiratorOther Tagsbranded 2branded 3fuelled 2basketball 2tips 2tips 3tips 4tips 5record 2record 3record 4record 5record 6record 7record 8record 9space 2space 3space 4space 5space 6space 7
(Date:5/16/2008)...M, Ala. A new study reveals the genetic identity ... responsible for sexual transmission, in unprecede...ues in the ongoing search for an effective HIV/AID...labama at Birmingham (UAB). The UAB team found tha...o sexual transmission. , Earlier studies have sh...
(Date:5/16/2008)...enowned team of experts in biomechanics and physio...Herr of the Massachusetts Institute of Technologys...theses worn by Oscar Pistorius, a 21-year-old Sout... him with an unfair advantage in the 400-meter rac...at the Rice University Locomotion Laboratory, unde...
(Date:5/15/2008)...Evolution is supposed to inch forward over eons, b...h called the threespine stickleback, the process c... a study led by researchers at Fred Hutchinson Can...print in the May 20 issue of Current Biology (Cell... of reverse evolution in nature, said senior autho...
(Date:5/15/2008)... human race was divided into two separate groups w... says a Tel Aviv University mathematician. Climate...ions may have caused and maintained the separation...ematical Sciences at Tel Aviv University, worked w...l Center to analyze African DNA. Their goal was to...
Breaking Biology News(10 mins):HIV infection stems from few viruses 2Breaking news: Study revives Olympic prospects for amputee sprinter 2Breaking news: Study revives Olympic prospects for amputee sprinter 3Researchers document rapid, dramatic 'reverse evolution' in the threespine stickleback fish 2Researchers document rapid, dramatic 'reverse evolution' in the threespine stickleback fish 3Long lost sisters 2Irradiation Almost Erases Risk of Food Poisoning 16539 1Irradiation Almost Erases Risk of Food Poisoning 16539 2Irradiation Almost Erases Risk of Food Poisoning 16539 3Irradiation Almost Erases Risk of Food Poisoning 16539 4Penn researchers discover modus operandi of heart muscle protein 16537 1Penn researchers discover modus operandi of heart muscle protein 16537 2Keith Denner Extends Current Technologys Chairman and CEO Options 16536 1Keith Denner Extends Current Technologys Chairman and CEO Options 16536 2Keith Denner Extends Current Technologys Chairman and CEO Options 16536 3Methodist Healthcare Memphis Hospitals Announces Termination of Tender Offers 16534 1Methodist Healthcare Memphis Hospitals Announces Termination of Tender Offers 16534 2(Date:5/16/2008)...cus on Millions of Children Still in Danger, NEW ...CEF and The,Advertising Council today announced a ...national public service announcements (PSAs) filme...cole Ritchie, Joel Madden, David,Duchovny, Tea Leo...of the,Myanmar cyclone. The Ad Council is distribu...
(Date:5/16/2008)...RNewswire/ -- ExamForce announced today the,hiring...ment Sales Manager.,Mongeon formerly headed up the...where he oversaw government sales and marketing in... security certifications in the IT,industry., Mon...left (ISC)2,Americas to spend more time with his t...
(Date:5/16/2008)...ly disseminated to community physicians, audit fin...- Partnerships between major academic cancer cente...ve way to spread cancer treatment advances, say re...ia. , Most new cancer treatments are created at...ovided at community hospitals, noted the researche...
(Date:5/16/2008).../PRNewswire-USNewswire/ -- Karin Weisburgh,senior...t publisher of,Consumer Reports magazine, was name... at CU,s Yonkers headquarters today., Ms. Weisbur...les up in,the winter and rides in shirt sleeves in...ong Quaker Ridge in New Rochelle, down Mill Road i...
Breaking Medicine News(10 mins):Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 3Health News:Partnerships Effective Communicators of Cancer Advances 2Health News:Westchester Cycle Club Awards Consumers Union Staffer Karin Weisburgh Commuter of the Year 2Health News:Westchester Cycle Club Awards Consumers Union Staffer Karin Weisburgh Commuter of the Year 3[0] Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities[0] ExamForce Hires Former (ISC)2 Americas Leader to Head Corporate and Government Sales Efforts[0] Partnerships Effective Communicators of Cancer Advances[0] Westchester Cycle Club Awards Consumers Union Staffer Karin Weisburgh Commuter of the Year
| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |